Central alpha-adrenergic systems as targets for hypotensive drugs.
D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D003000:Clonidine / Q000494:pharmacology; D003864:Depression, Chemical; D006439:Hemodynamics / Q000187:drug effects; D008750:Methyldopa / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D008750:Methyldopa; D003000:Clonidine; D009638:Norepinephrine